Application of Autological Adipose Tissue and its Products in the Treatment of Infected Wounds of Different Genesis
Open Access
- 24 November 2022
- journal article
- research article
- Published by VSMU N.N. Burdenko in Journal of Experimental and Clinical Surgery
- Vol. 15 (3) , 268-277
Abstract
Introduction. Transplantation of autologous adipose tissue and its products to stimulate the wound process is a rapidly developing area of regenerative medicine. Adaptation of the technology to the conditions of infected wound treatment is a great challenge.The aim of the study was to determine the most effective and safe technologies for obtaining, processing and transplanting autologous adipose tissue used to treat infected wounds.Material and methods. The authors searched for relevant papers published in 2011 to 2021 in electronic databases PubMed, eLIBRARY, Embase, Cyberleninka, Web of Science. The analysis included 30 sources: 5 RCTs, 16 clinical studies, 3 case reports, 1 systematic review, 2 literature reviews, and 4 sources published before 2011 due to their fundamental and practical significance for the scope of the issue.Results and discussions. Although the lipoaspiration procedure in patients with infected wounds is described as standard conventional one, it still has a number of significant features that distinguish it from the standard technology of aesthetic surgery. To treat lipoaspirate, both enzymatic and mechanical options were used with the same frequency. The main technique of introducing adipose tissue products was local intradermal injections into the edges and under the wound bed; in a few cases, applications on the wound surface were used, or a combination of these options. As recorded, the cellularity index of adipose tissue products ranged from (min) 1x104/ml to (max) 50x106/ml. It should also be noted that a unified terminology for adipose tissue products used for wound treatment has not yet been adopted, but the most common term is stromal-vascular adipose tissue fraction.Conclusions. Systematization of literature data on the use of autologous adipose tissue products for wound treatment has shown that at present this technology is safe, provided with an accessible instrumental base, has positive results and is being actively developed. Further randomized clinical trials, involving extensive and multiple wounds, are required to determine the minimum effective and maximum tolerable dose in the treatment of wounds with adipose tissue products. In addition, it is promising to develop new means and approaches for delivering adipose tissue products in the treatment of infected wounds of various origins.Keywords
This publication has 28 references indexed in Scilit:
- Débridement and Autologous Lipotransfer for Chronic Ulceration of the Diabetic Foot and Lower Limb Improves Wound HealingPlastic and Reconstructive Surgery, 2015
- Regional Implantation of Autologous Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients with Systemic SclerosisCell Transplantation, 2015
- Is it possible to use autologous adipose graft for wound repair in patients with coagulation disorders?Haemophilia, 2015
- A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistulaSurgery Today, 2015
- Fat Grafting for Treatment of Burns, Burn Scars, and Other Difficult WoundsClinics in Plastic Surgery, 2015
- Autologous Fat Grafting for Scleroderma-Induced Digital Ulcers. An Effective Technique in Patients with Systemic SclerosisHandchirurgie · Mikrochirurgie · Plastische Chirurgie, 2014
- Treatment of Early-Stage Pressure Ulcers by Using Autologous Adipose Tissue GraftsPlastic Surgery International, 2014
- Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial diseaseJournal of Surgical Research, 2013
- Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcersStem Cell Research, 2011
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001